9 participants
Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-05
- Start Date:
- 2023-05-03
- Completion:
- 2026-12-31
Conditions
- Hodgkin Lymphoma
Interventions
- DRUG
No Results Yet